BIIB
Price
$118.84
Change
-$0.67 (-0.56%)
Updated
Apr 25 closing price
Capitalization
31.34B
5 days until earnings call
GILD
Price
$103.17
Change
-$2.98 (-2.81%)
Updated
Apr 25 closing price
Capitalization
90.79B
101 days until earnings call
Ad is loading...

BIIB vs GILD

Header iconBIIB vs GILD Comparison
Open Charts BIIB vs GILDBanner chart's image
Biogen
Price$118.84
Change-$0.67 (-0.56%)
Volume$1.54M
Capitalization31.34B
Gilead Sciences
Price$103.17
Change-$2.98 (-2.81%)
Volume$14.21M
Capitalization90.79B
BIIB vs GILD Comparison Chart
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIIB vs. GILD commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Buy and GILD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (BIIB: $118.84 vs. GILD: $103.17)
Brand notoriety: BIIB and GILD are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 86% vs. GILD: 144%
Market capitalization -- BIIB: $31.34B vs. GILD: $90.79B
BIIB [@Pharmaceuticals: Major] is valued at $31.34B. GILD’s [@Pharmaceuticals: Major] market capitalization is $90.79B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 0 FA rating(s) are green whileGILD’s FA Score has 3 green FA rating(s).

  • BIIB’s FA Score: 0 green, 5 red.
  • GILD’s FA Score: 3 green, 2 red.
According to our system of comparison, GILD is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 5 TA indicator(s) are bullish while GILD’s TA Score has 4 bullish TA indicator(s).

  • BIIB’s TA Score: 5 bullish, 5 bearish.
  • GILD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GILD is a better buy in the short-term than BIIB.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а +0.19% price change this week, while GILD (@Pharmaceuticals: Major) price change was -1.31% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.20%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was -7.79%.

Reported Earning Dates

BIIB is expected to report earnings on Jul 23, 2025.

GILD is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+3.20% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GILD($90.8B) has a higher market cap than BIIB($31.3B). BIIB has higher P/E ratio than GILD: BIIB (26.95) vs GILD (16.20). GILD YTD gains are higher at: 12.476 vs. BIIB (-22.286). GILD has higher annual earnings (EBITDA): 10.5B vs. BIIB (2.04B). GILD has more cash in the bank: 7.26B vs. BIIB (1.05B). BIIB has less debt than GILD: BIIB (7.34B) vs GILD (25B). GILD has higher revenues than BIIB: GILD (27.1B) vs BIIB (9.84B).
BIIBGILDBIIB / GILD
Capitalization31.3B90.8B34%
EBITDA2.04B10.5B19%
Gain YTD-22.28612.476-179%
P/E Ratio26.9516.20166%
Revenue9.84B27.1B36%
Total Cash1.05B7.26B14%
Total Debt7.34B25B29%
FUNDAMENTALS RATINGS
BIIB vs GILD: Fundamental Ratings
BIIB
GILD
OUTLOOK RATING
1..100
5466
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
10017
SMR RATING
1..100
6788
PRICE GROWTH RATING
1..100
6540
P/E GROWTH RATING
1..100
961
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GILD's Valuation (33) in the Biotechnology industry is somewhat better than the same rating for BIIB (93). This means that GILD’s stock grew somewhat faster than BIIB’s over the last 12 months.

GILD's Profit vs Risk Rating (17) in the Biotechnology industry is significantly better than the same rating for BIIB (100). This means that GILD’s stock grew significantly faster than BIIB’s over the last 12 months.

BIIB's SMR Rating (67) in the Biotechnology industry is in the same range as GILD (88). This means that BIIB’s stock grew similarly to GILD’s over the last 12 months.

GILD's Price Growth Rating (40) in the Biotechnology industry is in the same range as BIIB (65). This means that GILD’s stock grew similarly to BIIB’s over the last 12 months.

GILD's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for BIIB (96). This means that GILD’s stock grew significantly faster than BIIB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIIBGILD
RSI
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
49%
Momentum
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
55%
MACD
ODDS (%)
Bullish Trend 1 day ago
45%
Bearish Trend 1 day ago
32%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
48%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
48%
Advances
ODDS (%)
Bullish Trend 13 days ago
54%
Bullish Trend 4 days ago
58%
Declines
ODDS (%)
Bearish Trend 11 days ago
69%
Bearish Trend 1 day ago
50%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
45%
Aroon
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
52%
View a ticker or compare two or three
Ad is loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XAGE0.16N/A
+2.63%
Longevity Health Holdings Inc
MGIC13.880.21
+1.54%
Magic Software Enterprises Ltd
FOXA49.350.33
+0.67%
Fox Corp
ICFI85.72-0.13
-0.15%
ICF International
SFWL0.94-0.05
-4.59%
Shengfeng Development Limited

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with OGN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then OGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
-0.56%
OGN - BIIB
49%
Loosely correlated
+0.66%
AMGN - BIIB
46%
Loosely correlated
+0.36%
NVS - BIIB
44%
Loosely correlated
+0.87%
PFE - BIIB
42%
Loosely correlated
+0.61%
AZN - BIIB
36%
Loosely correlated
+0.03%
More

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with JNJ. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
-2.81%
JNJ - GILD
41%
Loosely correlated
-0.23%
BMY - GILD
40%
Loosely correlated
-1.62%
PFE - GILD
36%
Loosely correlated
+0.61%
BIIB - GILD
35%
Loosely correlated
-0.56%
ABBV - GILD
35%
Loosely correlated
+3.15%
More